(Q27312323)
Statements
SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease (English)
0 references
2011
0 references
6
0 references
11
0 references
e27746
0 references
28 November 2011
1 reference
1 reference